Literature DB >> 10548217

Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: evidence of adrenal insufficiency?

F A Riordan1, A P Thomson, J M Ratcliffe, J A Sills, M J Diver, C A Hart.   

Abstract

OBJECTIVE: To measure admission cortisol and adrenocorticotrophic hormone (ACTH) levels in children with meningococcal disease to try and determine the prevalence of adrenal insufficiency.
DESIGN: Prospective observational study.
SETTING: Pediatric departments of four hospitals in Merseyside, United Kingdom. PATIENTS: Ninety-six children with meningococcal disease; 29 with hypotension, ten of whom died.
MEASUREMENTS AND MAIN RESULTS: Admission cortisol, ACTH, and proinflammatory cytokine levels were measured. Serial cortisol levels also were measured during the first 48 hrs. Significantly lower cortisol levels were found in those who died compared with survivors. Significantly higher ACTH levels also were found in those who died. However, no child had a cortisol level <5 microg/dL (<138 nmol/L) implying definite adrenal insufficiency. Three of 29 children with hypotension had plasma cortisol levels implying possible adrenal insufficiency (<18 microg/dL [<497 nmol/L]), but high ACTH levels were only found in one of those three. Cortisol levels decreased significantly after antibiotic treatment, unless steroid therapy was administered. ACTH levels did not correlate with cortisol or proinflammatory cytokine levels.
CONCLUSIONS: Children with meningococcal disease have a wide range of initial plasma cortisol levels, with lower levels found in those who die. Many factors may affect cortisol levels, but adrenal insufficiency is probably uncommon.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548217     DOI: 10.1097/00003246-199910000-00032

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Noradrenaline in meningococcal septic shock.

Authors:  J J Ligtenberg; J G Zijlstra; A R Girbes
Journal:  Intensive Care Med       Date:  2000-10       Impact factor: 17.440

Review 2.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

3.  Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Graziele Milioli; Jaqueline S Generoso; Andreza L Cipriano; Caroline S Costa; Ana Paula Moreira; Márcia Carvalho Vilela; Clarissa M Comim; Antonio Lucio Teixeira; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

4.  Initial observations regarding free cortisol quantification logistics among critically ill children.

Authors:  Jerry J Zimmerman; Ruth M Barker; Rhona Jack
Journal:  Intensive Care Med       Date:  2010-08-19       Impact factor: 17.440

5.  Steroids in septic shock: the confusion continues.

Authors:  Shane M Tibby
Journal:  Arch Dis Child       Date:  2007-07       Impact factor: 3.791

6.  Management of septic shock: where do we stand?

Authors:  J Sankar; R Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2009-01-07       Impact factor: 1.967

7.  A prospective multicenter study of adrenal function in critically ill children.

Authors:  Kusum Menon; Roxanne E Ward; Margaret L Lawson; Isabelle Gaboury; James S Hutchison; Paul C Hébert
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

8.  Management and Treatment Guidelines for Sepsis in Pediatric Patients.

Authors:  Nidal El-Wiher; Timothy T Cornell; Nranjany Kissoon; Thomas P Shanley
Journal:  Open Inflamm J       Date:  2011-10-07

Review 9.  Recent advances in sepsis and septic shock.

Authors:  Praveen Khilnani; Satish Deopujari; Joe Carcillo
Journal:  Indian J Pediatr       Date:  2008-09-04       Impact factor: 1.967

10.  ACTH and cortisol response to critical illness in term and late preterm newborns.

Authors:  E F Fernandez; R Montman; K L Watterberg
Journal:  J Perinatol       Date:  2008-11-06       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.